Lorcaserin Extended-Release Tablets and Obizur Intravenous
Determining the interaction of Lorcaserin Extended-Release Tablets and Obizur Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
Generic Name: antihemophilic factor
Brand name: Obizur, Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi
Synonyms: Obizur
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lorcaserin Extended-Release Tablets-Obredon
- Lorcaserin Extended-Release Tablets-Ocaliva
- Lorcaserin Extended-Release Tablets-Occlucort
- Lorcaserin Extended-Release Tablets-Occlusal-HP Topical
- Lorcaserin Extended-Release Tablets-Oceanic Selenium
- Lorcaserin Extended-Release Tablets-Ocella
- Obizur Intravenous-Lorcaserin Hydrochloride
- Obizur Intravenous-Lorcaserin Tablets
- Obizur Intravenous-Lorcet
- Obizur Intravenous-Lorcet Plus
- Obizur Intravenous-Lorcet Tablets
- Obizur Intravenous-Lorlatinib